• Je něco špatně v tomto záznamu ?

The release kinetics, antimicrobial activity and cytocompatibility of differently prepared collagen/hydroxyapatite/vancomycin layers: Microstructure vs. nanostructure

T. Suchý, M. Šupová, E. Klapková, V. Adamková, J. Závora, M. Žaloudková, Š. Rýglová, R. Ballay, F. Denk, M. Pokorný, P. Sauerová, M. Hubálek Kalbáčová, L. Horný, J. Veselý, T. Voňavková, R. Průša,

. 2017 ; 100 (-) : 219-229. [pub] 20170127

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031083

The aim of this study was to develop an osteo-inductive resorbable layer allowing the controlled elution of antibiotics to be used as a bone/implant bioactive interface particularly in the case of prosthetic joint infections, or as a preventative procedure with respect to primary joint replacement at a potentially infected site. An evaluation was performed of the vancomycin release kinetics, antimicrobial efficiency and cytocompatibility of collagen/hydroxyapatite layers containing vancomycin prepared employing different hydroxyapatite concentrations. Collagen layers with various levels of porosity and structure were prepared using three different methods: by means of the lyophilisation and electrospinning of dispersions with 0, 5 and 15wt% of hydroxyapatite and 10wt% of vancomycin, and by means of the electrospinning of dispersions with 0, 5 and 15wt% of hydroxyapatite followed by impregnation with 10wt% of vancomycin. The maximum concentration of the released active form of vancomycin characterised by means of HPLC was achieved via the vancomycin impregnation of the electrospun layers, whereas the lowest concentration was determined for those layers electrospun directly from a collagen solution containing vancomycin. Agar diffusion testing revealed that the electrospun impregnated layers exhibited the highest level of activity. It was determined that modification using hydroxyapatite exerts no strong effect on vancomycin evolution. All the tested samples exhibited sufficient cytocompatibility with no indication of cytotoxic effects using human osteoblastic cells in direct contact with the layers or in 24-hour infusions thereof. The results herein suggest that nano-structured collagen-hydroxyapatite layers impregnated with vancomycin following cross-linking provide suitable candidates for use as local drug delivery carriers.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031083
003      
CZ-PrNML
005      
20250121143454.0
007      
ta
008      
171025e20170127ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejps.2017.01.032 $2 doi
035    __
$a (PubMed)28132822
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Suchý, Tomáš $u Department of Composites and Carbon Materials, Institute of Rock Structure and Mechanics, Academy of Sciences of the Czech Republic, Prague 8, Czech Republic; Faculty of Mechanical Engineering, Czech Technical University in Prague, Prague 6, Czech Republic. Electronic address: suchyt@irsm.cas.cz.
245    14
$a The release kinetics, antimicrobial activity and cytocompatibility of differently prepared collagen/hydroxyapatite/vancomycin layers: Microstructure vs. nanostructure / $c T. Suchý, M. Šupová, E. Klapková, V. Adamková, J. Závora, M. Žaloudková, Š. Rýglová, R. Ballay, F. Denk, M. Pokorný, P. Sauerová, M. Hubálek Kalbáčová, L. Horný, J. Veselý, T. Voňavková, R. Průša,
520    9_
$a The aim of this study was to develop an osteo-inductive resorbable layer allowing the controlled elution of antibiotics to be used as a bone/implant bioactive interface particularly in the case of prosthetic joint infections, or as a preventative procedure with respect to primary joint replacement at a potentially infected site. An evaluation was performed of the vancomycin release kinetics, antimicrobial efficiency and cytocompatibility of collagen/hydroxyapatite layers containing vancomycin prepared employing different hydroxyapatite concentrations. Collagen layers with various levels of porosity and structure were prepared using three different methods: by means of the lyophilisation and electrospinning of dispersions with 0, 5 and 15wt% of hydroxyapatite and 10wt% of vancomycin, and by means of the electrospinning of dispersions with 0, 5 and 15wt% of hydroxyapatite followed by impregnation with 10wt% of vancomycin. The maximum concentration of the released active form of vancomycin characterised by means of HPLC was achieved via the vancomycin impregnation of the electrospun layers, whereas the lowest concentration was determined for those layers electrospun directly from a collagen solution containing vancomycin. Agar diffusion testing revealed that the electrospun impregnated layers exhibited the highest level of activity. It was determined that modification using hydroxyapatite exerts no strong effect on vancomycin evolution. All the tested samples exhibited sufficient cytocompatibility with no indication of cytotoxic effects using human osteoblastic cells in direct contact with the layers or in 24-hour infusions thereof. The results herein suggest that nano-structured collagen-hydroxyapatite layers impregnated with vancomycin following cross-linking provide suitable candidates for use as local drug delivery carriers.
650    12
$a antibakteriální látky $x aplikace a dávkování $x chemie $7 D000900
650    _2
$a nádorové buněčné linie $7 D045744
650    12
$a kolagen $x aplikace a dávkování $x chemie $7 D003094
650    12
$a lékové transportní systémy $7 D016503
650    12
$a hydroxyapatit $x aplikace a dávkování $x chemie $7 D017886
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a nanostruktury $x aplikace a dávkování $x chemie $7 D049329
650    _2
$a osteoblasty $x účinky léků $7 D010006
650    _2
$a krevní plazma $x chemie $7 D010949
650    _2
$a Staphylococcus aureus $x účinky léků $7 D013211
650    _2
$a Staphylococcus epidermidis $x účinky léků $7 D013212
650    12
$a vankomycin $x aplikace a dávkování $x chemie $7 D014640
655    _2
$a časopisecké články $7 D016428
700    1_
$a Šupová, Monika $u Department of Composites and Carbon Materials, Institute of Rock Structure and Mechanics, Academy of Sciences of the Czech Republic, Prague 8, Czech Republic.
700    1_
$a Klapková, Eva $u Department of Medical Chemistry and Clinical Biochemistry, Charles University, 2nd Medical School and University Hospital Motol, Prague 5, Czech Republic.
700    1_
$a Adamková, Václava $u Clinical Microbiology and ATB Centre, Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague 2, Czech Republic. $7 gn_A_00001461
700    1_
$a Závora, Jan $u Clinical Microbiology and ATB Centre, Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague 2, Czech Republic.
700    1_
$a Žaloudková, Margit $u Department of Composites and Carbon Materials, Institute of Rock Structure and Mechanics, Academy of Sciences of the Czech Republic, Prague 8, Czech Republic.
700    1_
$a Rýglová, Šárka $u Department of Composites and Carbon Materials, Institute of Rock Structure and Mechanics, Academy of Sciences of the Czech Republic, Prague 8, Czech Republic.
700    1_
$a Ballay, Rastislav $u 1st Department of Orthopaedics, 1st Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague 5, Czech Republic. $7 xx0327926
700    1_
$a Denk, František $u Department of Composites and Carbon Materials, Institute of Rock Structure and Mechanics, Academy of Sciences of the Czech Republic, Prague 8, Czech Republic; Faculty of Mechanical Engineering, Czech Technical University in Prague, Prague 6, Czech Republic.
700    1_
$a Pokorný, Marek $u Contipro a.s., R&D Department, Dolni Dobrouc, Czech Republic.
700    1_
$a Sauerová, Pavla $u Institute of Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University in Prague, Ke Karlovu 2, Prague 2, Czech Republic; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, Pilsen, Czech Republic.
700    1_
$a Hubálek Kalbáčová, Marie $u Institute of Inherited Metabolic Disorders, 1st Faculty of Medicine, Charles University in Prague, Ke Karlovu 2, Prague 2, Czech Republic; Biomedical Centre, Faculty of Medicine in Pilsen, Charles University in Prague, Alej Svobody 76, Pilsen, Czech Republic.
700    1_
$a Horný, Lukáš $u Faculty of Mechanical Engineering, Czech Technical University in Prague, Prague 6, Czech Republic.
700    1_
$a Veselý, Jan $u Faculty of Mechanical Engineering, Czech Technical University in Prague, Prague 6, Czech Republic.
700    1_
$a Voňavková, Tereza $u Faculty of Mechanical Engineering, Czech Technical University in Prague, Prague 6, Czech Republic.
700    1_
$a Průša, Richard $u Department of Medical Chemistry and Clinical Biochemistry, Charles University, 2nd Medical School and University Hospital Motol, Prague 5, Czech Republic.
773    0_
$w MED00001639 $t European journal of pharmaceutical sciences $x 1879-0720 $g Roč. 100 (20170127), s. 219-229
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28132822 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20250121143450 $b ABA008
999    __
$a ok $b bmc $g 1254676 $s 992110
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 100 $c - $d 219-229 $e 20170127 $i 1879-0720 $m European journal of pharmaceutical sciences $n Eur. j. pharm. sci. (Print) $x MED00001639
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace